Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis

[1]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[2]  L. Hedges,et al.  Introduction to Meta‐Analysis , 2009, International Coaching Psychology Review.

[3]  J. Ioannidis,et al.  Replication, Duplication, and Waste in a Quarter Million Systematic Reviews and Meta-Analyses. , 2018, Circulation. Cardiovascular quality and outcomes.

[4]  Jop de Vrieze.  The metawars. , 2018, Science.

[5]  Retraction: Comparison of acupuncture and other drugs for chronic constipation: A network meta-analysis , 2018, PloS one.

[6]  F. Naudet,et al.  Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate , 2018, Addiction.

[7]  J. Ioannidis,et al.  Overlapping network meta-analyses on the same topic: survey of published studies. , 2017, International journal of epidemiology.

[8]  Lorenzo Bertizzolo,et al.  Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy. , 2017, Journal of clinical epidemiology.

[9]  Mardge H. Cohen,et al.  Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results. , 2017, Contemporary clinical trials.

[10]  Shinichi Nakagawa,et al.  Nonindependence and sensitivity analyses in ecological and evolutionary meta‐analyses , 2017, Molecular ecology.

[11]  F. Altice,et al.  Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. , 2017, Drug and alcohol dependence.

[12]  Ewoud Schuit,et al.  Network meta-analyses performed by contracting companies and commissioned by industry , 2016, Systematic Reviews.

[13]  R. Gallop,et al.  Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial. , 2016, JAMA psychiatry.

[14]  John P A Ioannidis,et al.  The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. , 2016, The Milbank quarterly.

[15]  F. Naudet,et al.  Evaluation in alcohol use disorders – insights from the nalmefene experience , 2016, BMC Medicine.

[16]  T. Furukawa,et al.  Network meta-analyses should be the highest level of evidence in treatment guidelines , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[17]  F. Naudet.  Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin? , 2016, Pharmacopsychiatry.

[18]  D. Vlahov,et al.  Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men , 2016, Journal of acquired immune deficiency syndromes.

[19]  J. Ioannidis,et al.  Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications. , 2016, Journal of clinical epidemiology.

[20]  John P. A. Ioannidis,et al.  p-Curve and p-Hacking in Observational Research , 2016, PloS one.

[21]  M. Soyka,et al.  Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis , 2016, Pharmacopsychiatry.

[22]  S. Ebrahim,et al.  Meta-analyses with industry involvement are massively published and report no caveats for antidepressants. , 2016, Journal of clinical epidemiology.

[23]  John P A Ioannidis,et al.  Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. , 2015, Journal of clinical epidemiology.

[24]  Gerta Rücker,et al.  Network Meta-Analysis using Frequentist Methods , 2015 .

[25]  Kristian Thorlund,et al.  The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.

[26]  D. Oslin,et al.  Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[27]  L. Moja,et al.  Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review. , 2015, Journal of clinical epidemiology.

[28]  Kelly S. DeMartini,et al.  Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. , 2015, The Journal of clinical psychiatry.

[29]  A. Janssens,et al.  A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users , 2014, Genetics in Medicine.

[30]  A. Grey,et al.  A Case Study of Discordant Overlapping Meta-Analyses: Vitamin D Supplements and Fracture , 2014, PloS one.

[31]  N. Stafford.  German evaluation says new drug for alcohol dependence is no better than old one , 2014, BMJ : British Medical Journal.

[32]  Michael R. Wierzbicki,et al.  A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence. , 2014, The American journal on addictions.

[33]  Daniel J Fridberg,et al.  Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. , 2014, Alcoholism, clinical and experimental research.

[34]  L. Trinquart,et al.  Association between analytic strategy and estimates of treatment outcomes in meta-analyses. , 2014, JAMA.

[35]  B. Jaber,et al.  Understanding discordant meta-analyses of convective dialytic therapies for chronic kidney failure. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  W. van den Brink,et al.  Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study , 2014, Journal of psychopharmacology.

[37]  A. Braillon.  Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency , 2014, BMJ : British Medical Journal.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  K. Mann,et al.  A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence , 2013, European Neuropsychopharmacology.

[40]  Kristian Thorlund,et al.  The effects of excluding treatments from network meta-analyses: survey , 2013, BMJ : British Medical Journal.

[41]  D. Oslin,et al.  Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. , 2013, JAMA.

[42]  Tina Hernandez-Boussard,et al.  Overlapping meta-analyses on the same topic: survey of published studies , 2013, BMJ.

[43]  Huseyin Naci,et al.  Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers , 2013, BMC Medicine.

[44]  K. Thorlund,et al.  Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection , 2013, Clinical epidemiology.

[45]  R. Swift.  Naltrexone and Nalmefene: Any Meaningful Difference? , 2013, Biological Psychiatry.

[46]  K. Mann,et al.  Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene , 2013, Biological Psychiatry.

[47]  Harald Binder,et al.  A graphical tool for locating inconsistency in network meta-analyses , 2013, BMC Medical Research Methodology.

[48]  Jack Bowden,et al.  A sensitivity analysis framework for the treatment effect measure used in the meta-analysis of comparative binary data from randomised controlled trials , 2012, Statistics in medicine.

[49]  Gerta Rücker,et al.  Network meta‐analysis, electrical networks and graph theory , 2012, Research synthesis methods.

[50]  Issa J Dahabreh,et al.  GOSH – a graphical display of study heterogeneity , 2012, Research synthesis methods.

[51]  C. Kahler,et al.  A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men. , 2012, Journal of consulting and clinical psychology.

[52]  Philippe Ravaud,et al.  Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials , 2012, PloS one.

[53]  S. Davies.  The importance of PROSPERO to the National Institute for Health Research , 2012, Systematic Reviews.

[54]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[55]  R. F. Santos-Galduróz,et al.  The effects of polyunsaturated fatty acids in alcohol dependence treatment - a double-blind, placebo-controlled pilot study , 2011, BMC clinical pharmacology.

[56]  P. Randall,et al.  Gabapentin combined with naltrexone for the treatment of alcohol dependence. , 2011, The American journal of psychiatry.

[57]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[58]  John P A Ioannidis,et al.  Meta‐research: The art of getting it wrong , 2010, Research synthesis methods.

[59]  D. Oslin,et al.  A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. , 2010, The American journal of psychiatry.

[60]  P. L. Ribeiro,et al.  Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. , 2009, Drug and alcohol dependence.

[61]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[62]  S. Armeli,et al.  Targeted Naltrexone for Problem Drinkers , 2009, Journal of clinical psychopharmacology.

[63]  B. Brands,et al.  A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. , 2009, The American journal on addictions.

[64]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[65]  R. Makuch,et al.  Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. , 2009, The international journal of neuropsychopharmacology.

[66]  P. L. Ribeiro,et al.  The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment. , 2009, Alcohol.

[67]  R. Laranjeira,et al.  Ensaio clínico duplo-cego randomizado e placebocontrolado com naltrexona e intervenção breve no tratamento ambulatorial da dependência de álcool , 2009 .

[68]  P. L. Ribeiro,et al.  Comparing topiramate with naltrexone in the treatment of alcohol dependence. , 2008, Addiction.

[69]  J. Ioannidis.  Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.

[70]  D. Goldman,et al.  Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial. , 2008, Alcoholism, clinical and experimental research.

[71]  Kevin G Lynch,et al.  A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. , 2008, Alcoholism, clinical and experimental research.

[72]  R. Anton,et al.  Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist? , 2008, Alcoholism, clinical and experimental research.

[73]  K. Lynch,et al.  A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. , 2008, Addictive behaviors.

[74]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[75]  S. Shiffman,et al.  Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. , 2007, Alcoholism, clinical and experimental research.

[76]  E. Vamvakas,et al.  Why have meta‐analyses of randomized controlled trials of the association between non‐white‐blood‐cell‐reduced allogeneic blood transfusion and postoperative infection produced discordant results? , 2007, Vox sanguinis.

[77]  E. Löyttyniemi,et al.  Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. , 2007, Alcoholism, clinical and experimental research.

[78]  Maree Teesson,et al.  Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. , 2006, Addiction.

[79]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[80]  R. Woolson,et al.  Naltrexone Combined With Either Cognitive Behavioral or Motivational Enhancement Therapy for Alcohol Dependence , 2005, Journal of clinical psychopharmacology.

[81]  B. Rounsaville,et al.  Naltrexone and Disulfiram in Patients with Alcohol Dependence and Comorbid Psychiatric Disorders , 2005, Biological Psychiatry.

[82]  H. Kranzler,et al.  Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. , 2005, JAMA.

[83]  K. Brady,et al.  Effectiveness of naltrexone in a community treatment program. , 2004, Alcoholism, clinical and experimental research.

[84]  W. van den Brink,et al.  A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence. , 2004, Alcoholism, clinical and experimental research.

[85]  Richard D Riley,et al.  Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. , 2004, Journal of clinical epidemiology.

[86]  Sean O'Connor,et al.  Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers. , 2004, Addictive behaviors.

[87]  H. Kranzler,et al.  A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence , 2004, Journal of clinical psychopharmacology.

[88]  H. Kranzler,et al.  Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. , 2004, Alcoholism, clinical and experimental research.

[89]  J. Ahmadi,et al.  Naltrexone for alcohol-dependent patients , 2004, Irish journal of medical science.

[90]  J. Krystal,et al.  Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia , 2004, Psychopharmacology.

[91]  B. Jaber,et al.  Dialysis Membrane and Modality in Acute Renal Failure: Understanding Discordant Meta‐Analyses , 2003, Seminars in dialysis.

[92]  P. Bendtsen,et al.  A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. , 2003, Alcoholism, clinical and experimental research.

[93]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[94]  T. Wetterling,et al.  Lack of Efficacy of Naltrexone in the Prevention of Alcohol Relapse: Results From a German Multicenter Study , 2002, Journal of clinical psychopharmacology.

[95]  C. Caso,et al.  A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. , 2002, Alcoholism, clinical and experimental research.

[96]  S. Wutzke,et al.  Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting , 2002, The Medical journal of Australia.

[97]  R. Rosenheck,et al.  Naltrexone in the treatment of alcohol dependence. , 2001, The New England journal of medicine.

[98]  G. Whelan,et al.  Naltrexone for alcohol dependence: a randomized controlled trial. , 2001, Addiction.

[99]  G. Parker,et al.  Naltrexone in the treatment of male alcoholics—an effectiveness study in Singapore , 2001 .

[100]  J. Moncrieff,et al.  A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. , 2000, Alcohol and alcoholism.

[101]  J. Copas,et al.  Meta-analysis, funnel plots and sensitivity analysis. , 2000, Biostatistics.

[102]  H. Kranzler,et al.  Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence: A Placebo-Controlled Trial , 2000, Neuropsychopharmacology.

[103]  J. Rybakowski,et al.  Naltrexone exerts a favourable effect on plasma lipids in abstinent patients with alcohol dependence. , 2000, Alcohol and alcoholism.

[104]  R. Anton,et al.  Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. , 1999, The American journal of psychiatry.

[105]  B. Mason,et al.  A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. , 1999, Archives of general psychiatry.

[106]  H. Kranzler,et al.  Naltrexone treatment of comorbid alcohol and cocaine use disorders , 1998, Psychopharmacology.

[107]  J. Balldin,et al.  The Swedish Naltrexone study, present results , 1998, European Psychiatry.

[108]  A. Alterman,et al.  Naltrexone and alcohol dependence. Role of subject compliance. , 1997, Archives of general psychiatry.

[109]  G. Guyatt,et al.  Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. , 1996, JAMA.

[110]  B. Mason,et al.  A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence , 1994 .

[111]  C. France,et al.  Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys. , 1994, The Journal of pharmacology and experimental therapeutics.

[112]  B. Mason,et al.  A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. , 1994, Alcoholism, clinical and experimental research.

[113]  B. Rounsaville,et al.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.

[114]  A. Alterman,et al.  Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.

[115]  STRESS ULCER PROPHYLAXIS IN CRITICALLY ILL PATIENTS , 1989, The Lancet.

[116]  References , 1971 .